BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29039106)

  • 1. Improved Ultrafiltration Method to Measure Drug Release from Nanomedicines Utilizing a Stable Isotope Tracer.
    Skoczen SL; Stern ST
    Methods Mol Biol; 2018; 1682():223-239. PubMed ID: 29039106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable isotope method to measure drug release from nanomedicines.
    Skoczen S; McNeil SE; Stern ST
    J Control Release; 2015 Dec; 220(Pt A):169-174. PubMed ID: 26596375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing Pharmacokinetics of Marketed Nanomedicine Formulations Using a Stable Isotope Tracer Assay.
    Skoczen SL; Snapp KS; Crist RM; Kozak D; Jiang X; Liu H; Stern ST
    ACS Pharmacol Transl Sci; 2020 Jun; 3(3):547-558. PubMed ID: 32566919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrafiltration vs equilibrium dialysis for determination of free fraction.
    Bowers WF; Fulton S; Thompson J
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():49-60. PubMed ID: 6705427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When Is It Important to Measure Unbound Drug in Evaluating Nanomedicine Pharmacokinetics?
    Stern ST; Martinez MN; Stevens DM
    Drug Metab Dispos; 2016 Dec; 44(12):1934-1939. PubMed ID: 27670412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafiltration and subsequent high performance liquid chromatography for in vivo determinations of the protein binding of etoposide.
    Liliemark E; Herngren L; Pettersson B; Peterson C; Liliemark J
    Cancer Lett; 1996 Aug; 106(1):91-6. PubMed ID: 8827051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of unbound docetaxel and paclitaxel in plasma by ultrafiltration and liquid chromatography-tandem mass spectrometry.
    Mortier KA; Lambert WE
    J Chromatogr A; 2006 Mar; 1108(2):195-201. PubMed ID: 16472531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of drug-protein binding by using immobilized human serum albumin liquid chromatography-mass spectrometry.
    Cheng Y; Ho E; Subramanyam B; Tseng JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):67-73. PubMed ID: 15282095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques.
    Mayer LD; St-Onge G
    Anal Biochem; 1995 Dec; 232(2):149-57. PubMed ID: 8747469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of total and free docetaxel concentration in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry.
    Rigo-Bonnin R; Cobo-Sacristán S; Gonzalo-Diego N; Colom H; Muñoz-Sánchez C; Urruticoechea A; Falo C; Alía P
    J Pharm Biomed Anal; 2016 Jan; 117():140-9. PubMed ID: 26350560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Temperature-Dependent Drug Release of Solubilizing Nanoformulations Using the SITUA.
    Stern ST; Skoczen SL; Park YH
    Methods Mol Biol; 2024; 2789():301-311. PubMed ID: 38507012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of unbound drug concentration and protein-drug binding fraction in plasma.
    Liu Z; Li F; Huang Y
    Biomed Chromatogr; 1999 Jun; 13(4):262-6. PubMed ID: 10416057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of drug binding to plasma proteins using competitive equilibrium binding to dextran-coated charcoal.
    Berezhkovskiy LM
    J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5):595-608. PubMed ID: 16841186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane® in rodent and non-human primate models using a stable isotope tracer assay.
    Hwang D; Vinod N; Skoczen SL; Ramsey JD; Snapp KS; Montgomery SA; Wang M; Lim C; Frank JE; Sokolsky-Papkov M; Li Z; Yuan H; Stern ST; Kabanov AV
    Biomaterials; 2021 Nov; 278():121140. PubMed ID: 34634661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioanalysis of therapeutic peptides: differentiating between total and anti-drug antibody bound drug using liquid chromatography-tandem mass spectrometry quantitation.
    Heinig K; Wirz T; Schick E; Guenzi A
    J Chromatogr A; 2013 Nov; 1316():69-77. PubMed ID: 24119751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anaerobic serum ultrafiltration--a new method for determination of protein-binding rates of drugs under physiological conditions (author's transl)].
    Paschen K; Bautz W; Bohner J
    Arzneimittelforschung; 1976; 26(12):2137-41. PubMed ID: 1037262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of volume ratio of ultrafiltrate of sample on the analysis of non-protein binding drugs in human plasma.
    Dong WC; Zhang JF; Hou ZL; Jiang XH; Zhang FC; Zhang HF; Jiang Y
    Analyst; 2013 Nov; 138(24):7369-75. PubMed ID: 24165752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equilibrium gel filtration to measure plasma protein binding of very highly bound drugs.
    Weiss HM; Gatlik E
    J Pharm Sci; 2014 Feb; 103(2):752-9. PubMed ID: 24375113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of drug binding to plasma proteins using a variant of equilibrium dialysis.
    Eriksson MA; Gabrielsson J; Nilsson LB
    J Pharm Biomed Anal; 2005 Jul; 38(3):381-9. PubMed ID: 15925237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-protein-binding determination of stilbene glucoside using cloud-point extraction and comparison with ultrafiltration and equilibrium dialysis.
    Wang C; Wang Q; Yuan Z; Liu W; Gu J; Zhang L
    Drug Dev Ind Pharm; 2010 Mar; 36(3):307-14. PubMed ID: 19670965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.